Expert Opinion

This decision leaves the door open for other plaintiffs who may bring a similar challenge against the FDA and mifepristone in the future.

"You need to stay up to the minute on developments," said Mark S. Goldstein, a labor and employment lawyer at Reed Smith. "We have to be able to be flexible and pivot quite quickly, with the patchwork of employment laws at the state and local level."

Employers are advised to work closely with labor and employment counsel in evaluating options.

Employers should train supervisors on how to receive and respond to PWFA accommodation requests.

In mid-February, CMS released revised instructions for the highly anticipated third RxDC reports, which encompass the 2023 calendar year and are due…

An employee is suing Johnson & Johnson for breaching their fiduciary duty of effectively managing their health benefits. This could drive major change in the industry.

Over the last two years, a compliance tidal wave has loomed over employers and their benefit advisors. The crest of this massive wave has begun to touch down upon fiduciaries of employer groups, so how can benefit advisors stay dry?

Regardless of its outcome, this class action will dramatically change pharmacy benefit management and the standard of care to which management will be held on benefit design.